These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 26459286)

  • 1. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
    Kala R; Shah HN; Martin SL; Tollefsbol TO
    BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells.
    Kala R; Tollefsbol TO
    PLoS One; 2016; 11(5):e0155057. PubMed ID: 27159275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
    Daniel M; Tollefsbol TO
    J Cell Biochem; 2018 Apr; 119(4):3326-3337. PubMed ID: 29125889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
    Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
    FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
    Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
    Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer.
    Merino VF; Cho S; Nguyen N; Sadik H; Narayan A; Talbot C; Cope L; Zhou XC; Zhang Z; Győrffy B; Sukumar S
    Breast Cancer Res; 2018 Nov; 20(1):145. PubMed ID: 30486871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.
    Royston KJ; Udayakumar N; Lewis K; Tollefsbol TO
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
    Sharma M; Tollefsbol TO
    Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
    Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
    Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
    [No Abstract]   [Full Text] [Related]  

  • 10. Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation.
    Kilic Eren M; Kilincli A; Eren Ö
    PLoS One; 2015; 10(4):e0124837. PubMed ID: 25924011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
    Hsieh TC; Wu JM
    Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line.
    Kumari S; Mohan MG; Shailender G; Badana AK; Malla RR
    J Cell Biochem; 2019 Oct; 120(10):18104-18116. PubMed ID: 31172606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
    Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
    Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Modulates SIRT1 and DNMT Functions and Restores LINE-1 Methylation Levels in ARPE-19 Cells under Oxidative Stress and Inflammation.
    Maugeri A; Barchitta M; Mazzone MG; Giuliano F; Basile G; Agodi A
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
    Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
    Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
    Wokoun U; Hellriegel M; Emons G; Gründker C
    Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype.
    Simpson NE; Tryndyak VP; Pogribna M; Beland FA; Pogribny IP
    Epigenetics; 2012 Dec; 7(12):1413-20. PubMed ID: 23117580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic⁻Mediating Machinery.
    Gao Y; Tollefsbol TO
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes.
    Guo Y; Zhang L; Li F; Hu CP; Zhang Z
    Eur J Pharmacol; 2016 Apr; 776():26-33. PubMed ID: 26921129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.